Infection with Strongyloides stercoralis is a significant global public health problem. Hyperinfection syndrome occurs in immunocompromised hosts and is associated with chronic steroid therapy. If unrecognized, it is associated with significant morbidity and mortality. Available regimens for the treatment of S. stercoralis in humans include oral agents and infrequently subcutaneous formulations.
From the *Departments of Medicine and †Infectious Diseases, Danbury Hospital, Danbury, CT.
Correspondence to: John G. Stratidis, MD, Section of Infectious Diseases, Danbury Hospital, Danbury, CT. E-mail: email@example.com.
The authors have no funding or conflicts of interest to disclose.